Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Zogenix to sell Sumavel DosePro to Endo

April 25, 2014

Medivir and HemoShear form collaboration

April 25, 2014

Biogen Idec and Quintiles form clinical development partnership

April 25, 2014

Hydra Biosciences and Boehringer Ingelheim to develop drugs for CNS disorders

April 25, 2014

Immatics to continue developing IMA-950 vaccine for glioblastoma

April 25, 2014

Lupin and Yoshindo to create joint venture

April 24, 2014

Courtagen to genetically profile patients at Connecticut Children's Autism Neurogenetics Clinic

April 24, 2014

Biodel and HEC Pharm subsidiary to develop ultra-rapid-acting insulin aspart

April 24, 2014

GlaxoSmithKline and Novartis make major restructuring deal

April 23, 2014

Sentinel Oncology and Oncothyreon to develop and commercialize Chk1 inhibitors

April 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.